标题
Molecular diagnostics of myeloproliferative neoplasms
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 95, Issue 4, Pages 270-279
出版商
Wiley
发表日期
2015-05-07
DOI
10.1111/ejh.12578
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms
- (2015) Amy V. Jones et al. LEUKEMIA RESEARCH
- A CALR Mutation Preceding BCR-ABL1 in an Atypical Myeloproliferative Neoplasm
- (2015) Xénia Cabagnols et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing
- (2015) Martin M. J. Kirschner et al. PLoS One
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
- (2014) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events
- (2014) Alberto Alvarez-Larrán et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
- (2014) E. Rumi et al. BLOOD
- Presence of calreticulin mutations in JAK2-negative polycythemia vera
- (2014) J. Broseus et al. BLOOD
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- JAK2V617F andCALRmutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort
- (2014) Gillian McGaffin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Assessment ofCALRmutations in myelofibrosis patients, post-allogeneic stem cell transplantation
- (2014) Karl Haslam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Myeloproliferative Neoplasms: JAK2 Signaling Pathway as a Central Target for Therapy
- (2014) Florence Pasquier et al. Clinical Lymphoma Myeloma & Leukemia
- JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
- (2014) C. Nielsen et al. HAEMATOLOGICA
- Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations
- (2014) H. Andrikovics et al. HAEMATOLOGICA
- Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis
- (2014) E. Lippert et al. HAEMATOLOGICA
- Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR
- (2014) E. Kinz et al. International Journal of Laboratory Hematology
- Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis
- (2014) J Broséus et al. LEUKEMIA
- CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
- (2014) A Tefferi et al. LEUKEMIA
- CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
- (2014) A Tefferi et al. LEUKEMIA
- Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact
- (2014) A Tefferi et al. LEUKEMIA
- Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia
- (2014) Bruno Cassinat et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Resolution Melting Analysis: A Rapid and Accurate Method to Detect CALR Mutations
- (2014) Cristina Bilbao-Sieyro et al. PLoS One
- Quantification of JAK2V617F mutation by next-generation sequencing technology
- (2013) Emna Abdelhamid et al. AMERICAN JOURNAL OF HEMATOLOGY
- Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
- (2013) G. Rotunno et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Mutations in the RNA splicing machinery genes in myelofibrotic transformation of essential thrombocythaemia and polycythaemia vera
- (2013) Luz Martínez-Avilés et al. BRITISH JOURNAL OF HAEMATOLOGY
- Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms
- (2013) Yuewen Fu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse
- (2013) T. Lange et al. HAEMATOLOGICA
- Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing
- (2013) Francisca Ferrer-Marín et al. Journal of Hematology & Oncology
- A Multiplexed Fragment Analysis-Based Assay for Detection of JAK2 Exon 12 Mutations
- (2013) Larissa V. Furtado et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Detection of MPL Mutations by a Novel Allele-Specific PCR-Based Strategy
- (2013) Larissa V. Furtado et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
- (2013) E Tenedini et al. LEUKEMIA
- Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
- (2013) J V Jovanovic et al. LEUKEMIA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating CBL mutations are associated with a distinct MDS/MPN phenotype
- (2012) Juliana Schwaab et al. ANNALS OF HEMATOLOGY
- Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection ofJAK2V617F and other relevant mutations
- (2012) Anthony J. Bench et al. BRITISH JOURNAL OF HAEMATOLOGY
- Quantitative bead-based assay for detection ofJAK2exon 12 mutations
- (2012) Velizar Shivarov et al. LEUKEMIA & LYMPHOMA
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Sensitive Quantitative Real-Time PCR Assay for Determination of Mutant JAK2 Exon 12 Allele Burden
- (2012) Lasse Kjær et al. PLoS One
- EZH2 mutational status predicts poor survival in myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms
- (2011) D. Pietra et al. HAEMATOLOGICA
- Nested High-Resolution Melting Curve Analysis
- (2011) Serge Carillo et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
- (2011) A Kohlmann et al. LEUKEMIA
- DNMT3A mutations in myeloproliferative neoplasms
- (2011) F Stegelmann et al. LEUKEMIA
- SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
- (2011) T L Lasho et al. LEUKEMIA
- Novel multiplex bead-based assay with LNA-modified probes for detection of MPL exon 10 mutations
- (2011) Milena I. Ivanova et al. LEUKEMIA RESEARCH
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT
- (2010) H Alchalby et al. BONE MARROW TRANSPLANTATION
- Clinical utility of routineMPLexon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis
- (2010) Elaine M. Boyd et al. BRITISH JOURNAL OF HAEMATOLOGY
- Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutations
- (2010) Laura Millecker et al. CANCER GENETICS AND CYTOGENETICS
- Detection of Exon 12 Mutations in the JAK2 Gene
- (2010) Todd S. Laughlin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
- (2010) C Cleyrat et al. LEUKEMIA
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
- (2010) A Tefferi et al. LEUKEMIA
- JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation
- (2009) N. Kroger et al. BLOOD
- Sensitive detection of MPLW515L/K mutations by amplification refractory mutation system (ARMS)-PCR
- (2009) Jian Zhuge et al. CLINICA CHIMICA ACTA
- Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
- (2009) S. Schnittger et al. HAEMATOLOGICA
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
- (2008) S. Li et al. BLOOD
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy
- (2008) F. Girodon et al. HAEMATOLOGICA
- Concordance of assays designed for the quantification of JAK2V617F: a multicenter study
- (2008) E. Lippert et al. HAEMATOLOGICA
- Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis
- (2008) S. Schnittger et al. HAEMATOLOGICA
- JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis
- (2008) P. Guglielmelli et al. HAEMATOLOGICA
- Rapid real-time PCR assay for detection ofMPL W515Lmutation in patients with chronic myeloproliferative disorders
- (2008) M. GHADERI et al. International Journal of Laboratory Hematology
- A Sensitive Detection Method for MPLW515L or MPLW515K Mutation in Chronic Myeloproliferative Disorders with Locked Nucleic Acid-Modified Probes and Real-Time Polymerase Chain Reaction
- (2008) Alessandro Pancrazzi et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started